Biomarkers in acute graft-versus-host disease: new insights

por Srinagesh, Hrishikesh K., Levine, John E., Ferrara, James L.M.
Publicado 2019

Tisch Cancer Institute Scholars Program: Mentored Cancer Research Training Pipeline for Medical Students

por Ben-David, Kaitlyn, Lin, Jenny J., Ferrara, James L. M., Gabrilove, Janice L.
Publicado 2021

Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis

por Reddy, Pavan, Teshima, Takanori, Kukuruga, Mark, Ordemann, Rainer, Liu, Chen, Lowler, Kathy, Ferrara, James L.M.
Publicado 2001

Essential Role for the P55 Tumor Necrosis Factor Receptor in Regulating Hematopoiesis at a Stem Cell Level

por Rebel, Vivienne I., Hartnett, Sheila, Hill, Geoffrey R., Lazo-Kallanian, Suzan B., Ferrara, James L.M., Sieff, Colin A.
Publicado 1999

Microbial metabolite sensor GPR43 controls severity of experimental GVHD

por Fujiwara, Hideaki, Docampo, Melissa D., Riwes, Mary, Peltier, Daniel, Toubai, Tomomi, Henig, Israel, Wu, S. Julia, Kim, Stephanie, Taylor, Austin, Brabbs, Stuart, Liu, Chen, Zajac, Cynthia, Oravecz-Wilson, Katherine, Sun, Yaping, Núñez, Gabriel, Levine, John E., van den Brink, Marcel R.M., Ferrara, James L. M., Reddy, Pavan
Publicado 2018

Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use

por Weber, Daniela, Weber, Markus, Meedt, Elisabeth, Ghimire, Sakhila, Wolff, Daniel, Edinger, Matthias, Poeck, Hendrik, Hiergeist, Andreas, Gessner, André, Ayuk, Francis, Roesler, Wolf, Wölfl, Matthias, Kraus, Sabrina, Zeiser, Robert, Bertrand, Hannah, Bader, Peter, Ullrich, Evelyn, Eder, Matthias, Gleich, Sigrun, Young, Rachel, Herr, Wolfgang, Levine, John E., Ferrara, James L. M., Holler, Ernst
Publicado 2022

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation

por Pidala, Joseph, Beato, Francisca, Kim, Jongphil, Betts, Brian, Jim, Heather, Sagatys, Elizabeth, Levine, John E., Ferrara, James L.M., Ozbek, Umut, Ayala, Ernesto, Davila, Marco, Fernandez, Hugo F., Field, Teresa, Kharfan-Dabaja, Mohamed A., Khaira, Divis, Khimani, Farhad, Locke, Frederick L., Mishra, Asmita, Nieder, Michael, Nishihori, Taiga, Perez, Lia, Riches, Marcie, Anasetti, Claudio
Publicado 2018

The utility of biomarkers in acute GVHD prognostication

por Spyrou, Nikolaos, Akahoshi, Yu, Ayuk, Francis, Holler, Ernst, Choe, Hannah, Etra, Aaron, Hogan, William J., Rösler, Wolf, Hexner, Elizabeth, DeFilipp, Zachariah, Reshef, Ran, Chanswangphuwana, Chantiya, Qayed, Muna, Kraus, Sabrina, Eder, Matthias, Javorniczky, Nora Rebeka, Grupp, Stephan A., Kitko, Carrie L., Merli, Pietro, Aguayo-Hiraldo, Paibel, Wölfl, Matthias, Baez, Janna, Beheshti, Rahnuma, Eng, Gilbert, Gleich, Sigrun, Katsivelos, Nikolaos, Khan, Alina, Kowalyk, Steven, Morales, George, Young, Rachel, Nakamura, Ryotaro, Chen, Yi-Bin, Levine, John E., Ferrara, James L. M.
Publicado 2023

Disease Risk and GVHD Biomarkers Can Stratify Patients For Risk of Relapse and Non-Relapse Mortality Post Hematopoietic Cell Transplant

por Aziz, Mina D., Shah, Jay, Kapoor, Urvi, Dimopoulos, Christina, Anand, Sarah, Augustine, Allan, Ayuk, Francis, Chaudhry, Mohammed, Chen, Yi-Bin, Choe, Hannah K., Etra, Aaron, Gergoudis, Stephanie, Hartwell, Matthew J., Hexner, Elizabeth O., Hogan, William J., Kitko, Carrie L., Kowalyk, Steven, Kröger, Nicolaus, Merli, Pietro, Morales, George, Nakamura, Ryotaro, Ordemann, Rainer, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Schreiner, Elisabeth, Srinagesh, Hrishikesh, Wölfl, Matthias, Wudhikarn, Kitsada, Yanik, Gregory, Young, Rachel, Özbek, Umut, Ferrara, James L.M., Levine, John E.
Publicado 2020

Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

por Etra, Aaron, Gergoudis, Stephanie, Morales, George, Spyrou, Nikolaos, Shah, Jay, Kowalyk, Steven, Ayuk, Francis, Baez, Janna, Chanswangphuwana, Chantiya, Chen, Yi-Bin, Choe, Hannah, DeFilipp, Zachariah, Gandhi, Isha, Hexner, Elizabeth, Hogan, William J., Holler, Ernst, Kapoor, Urvi, Kitko, Carrie L., Kraus, Sabrina, Lin, Jung-Yi, Al Malki, Monzr, Merli, Pietro, Pawarode, Attaphol, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Van Hyfte, Grace, Weber, Daniela, Wölfl, Matthias, Young, Rachel, Özbek, Umut, Ferrara, James L. M., Levine, John E.
Publicado 2022

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

por Akahoshi, Yu, Spyrou, Nikolaos, Hogan, William J., Ayuk, Francis, DeFilipp, Zachariah, Weber, Daniela, Choe, Hannah K., Hexner, Elizabeth O., Rösler, Wolf, Etra, Aaron M., Sandhu, Karamjeet, Yanik, Gregory A., Chanswangphuwana, Chantiya, Kitko, Carrie L., Reshef, Ran, Kraus, Sabrina, Wölfl, Matthias, Eder, Matthias, Bertrand, Hannah, Qayed, Muna, Merli, Pietro, Grupp, Stephan A., Aguayo-Hiraldo, Paibel, Schechter, Tal, Ullrich, Evelyn, Baez, Janna, Beheshti, Rahnuma, Gleich, Sigrun, Kowalyk, Steven, Morales, George, Young, Rachel, Kwon, Deukwoo, Nakamura, Ryotaro, Levine, John E., Ferrara, James L. M., Chen, Yi-Bin
Publicado 2023

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

por Al Malki, Monzr M., London, Kaitlyn, Baez, Janna, Akahoshi, Yu, Hogan, William J., Etra, Aaron, Choe, Hannah, Hexner, Elizabeth, Langston, Amelia, Abhyankar, Sunil, Ponce, Doris M., DeFilipp, Zachariah, Kitko, Carrie L., Adekola, Kehinde, Reshef, Ran, Ayuk, Francis, Capellini, Alexandra, Chanswangphuwana, Chantiya, Eder, Matthias, Eng, Gilbert, Gandhi, Isha, Grupp, Stephan, Gleich, Sigrun, Holler, Ernst, Javorniczky, Nora Rebeka, Kasikis, Stelios, Kowalyk, Steven, Morales, George, Özbek, Umut, Rösler, Wolf, Spyrou, Nikolaos, Yanik, Gregory, Young, Rachel, Chen, Yi-Bin, Nakamura, Ryotaro, Ferrara, James L. M., Levine, John E.
Publicado 2023